Researchers are studying relapses in anti-NMDAR encephalitis, with some analyses focusing on recovery outcomes and relapse rates over several years. The condition appears to pose diagnostic and therapeutic challenges, and studies are exploring various aspects, including clinical symptoms, testing, and treatment efficacy. The available information suggests that relapses may be a significant concern, but the specifics of the condition and its management are still being investigated.